POTEE: Potential Drug Target and Biomarker for Male and Female Reproductive Systems Cancer

Target Name: POTEE

NCBI ID: G445582

POTEE

POTEE: Potential Drug Target and Biomarker for Male and Female Reproductive Systems Cancer

Prostate-Ovary-Testis-Placenta (POTEE) is a protein that is expressed in the prostate, ovary, testis, and placenta. It is a transmembrane protein that consists of four distinct subunits: P4UF1, P4UF2, P4UF3, and P4UF4. POTEE plays a critical role in the development, maintenance, and regression of the male reproductive system, and it is also involved in the development and maintenance of the female reproductive system.

POTEE is a protein that is expressed in various organs and tissues throughout the body, including the prostate, ovary, testis, and placenta. It is a transmembrane protein that consists of four distinct subunits: P4UF1, P4UF2, P4UF3, and P4UF4. These subunits are located on the surface of each of the four organs and tissues that express POTEE.

One of the subunits of POTEE, P4UF1, is also known as PSMA-1 (prostate-specific Marnein-1). PSMA-1 is a potent negative regulator of androgen signaling in the prostate, and it is also involved in the development and maintenance of prostate cancer.

Another subunit of POTEE is P4UF2, which is also known as OVASIN (ovary-specific Marn-2). OVASIN is involved in the development and maintenance of ovarian cancer, and it is also a potent negative regulator of androgen signaling in the ovary.

P4UF3 is known as TSPO-2 (testis-specific marn-2). TSPO-2 is involved in the development and maintenance of testicular cancer, and it is also a potent negative regulator of androgen signaling in the testis.

The final subunit of POTEE is P4UF4, which is also known as PLACT (placenta-specific marn-4). PLACT is involved in the development and maintenance of placenta cancer, and it is also a potent negative regulator of androgen signaling in the placenta.

POTEE is a critical protein that is involved in the development, maintenance, and regression of the male and female reproductive systems. It is also involved in the development and maintenance of various cancers, including prostate, ovarian, and testicular cancer. As a result, POTEE is a potential drug target and biomarker for these cancers.

In conclusion, POTEE is a transmembrane protein that is expressed in various organs and tissues throughout the body, including the prostate, ovary, testis, and placenta. It plays a critical role in the development, maintenance, and regression of the male and female reproductive systems, and it is also involved in the development and maintenance of various cancers, including prostate, ovarian, and testicular cancer. As a result, POTEE is a potential drug target and biomarker for these cancers. Further research is needed to fully understand the role of POTEE in the development and treatment of these cancers.

Protein Name: POTE Ankyrin Domain Family Member E

The "POTEE Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POTEE comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets